Who
Christian Hassig
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Boundless Bio; Chief Scientific Officer, Sierra Oncology.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 6 Mar 2018
- Last trade
- 23 Jan 2026
- Last filed
- 26 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jan 2026filed 26 Jan 2026 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —230,000 at $0.00 | filing |
| 23 Jan 2026filed 26 Jan 2026 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —230,000 at $0.00 | filing |
| 22 Jan 2025filed 23 Jan 2025 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —95,000 at $0.00 | filing |
| 19 Aug 2024filed 20 Aug 2024 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —10,256 | filing |
| 19 Aug 2024filed 20 Aug 2024 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —62,820 | filing |
| 19 Aug 2024filed 20 Aug 2024 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —94,871 | filing |
| 19 Aug 2024filed 20 Aug 2024 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —76,173 | filing |
| 19 Aug 2024filed 20 Aug 2024 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —48,703 | filing |
| 19 Aug 2024filed 20 Aug 2024 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —10,256 | filing |
| 19 Aug 2024filed 20 Aug 2024 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —62,820 | filing |
| 19 Aug 2024filed 20 Aug 2024 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —94,871 | filing |
| 19 Aug 2024filed 20 Aug 2024 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —76,173 | filing |
| 19 Aug 2024filed 20 Aug 2024 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —48,703 | filing |
| 27 Mar 2024filed 29 Mar 2024 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —48,703 at $0.00 | filing |
| 4 Mar 2019filed 5 Mar 2019 | Sierra Oncologyoption or derivative | SEC FORM 4 Code A | —155,000 at $0.00 | filing |
| 6 Mar 2018filed 7 Mar 2018 | Sierra Oncologyoption or derivative | SEC FORM 4 Code A | —205,180 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.